Medifast (MED) Assets Average (2011 - 2026)

Medifast has reported Assets Average for 16 years, with the latest figure at $250.0 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average fell 11.38% year-over-year to $250.0 million; the trailing twelve-month figure through Mar 2026 stood at $250.0 million (down 11.38% YoY), and the FY2025 full-year result was $266.1 million, down 10.42% from the prior year.
• Assets Average for Q1 2026 stood at $250.0 million, down from $258.1 million in the prior quarter.
• The five-year high for Assets Average was $409.9 million in Q1 2022, with the low at $250.0 million in Q1 2026.
• Historically, Assets Average has averaged $308.1 million across 5 years, with a median of $306.3 million in 2024.
• Annual changes were most pronounced in 2022 — Assets Average soared 36.06% — and 2023, when it decreased 22.19%.
• Medifast's Assets Average stood at $321.3 million in 2022, then fell by 1.97% to $315.0 million in 2023, then dropped by 8.65% to $287.7 million in 2024, then declined by 10.3% to $258.1 million in 2025, then retreated by 3.13% to $250.0 million in 2026.
• The last three Assets Average figures came in at $250.0 million (Q1 2026), $258.1 million (Q4 2025), and $268.8 million (Q3 2025), per Business Quant data.